- Home
- COGT vs FMBH Comparison
COGT vs FMBH Comparison
Compare COGT & FMBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- FMBH
- Stock Information
- Founded
- COGT 2014
- FMBH 1865
- Country
- COGT United States
- FMBH United States
- Employees
- COGT N/A
- FMBH N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- FMBH Major Banks
- Sector
- COGT Health Care
- FMBH Finance
- Exchange
- COGT Nasdaq
- FMBH Nasdaq
- Market Cap
- COGT 1.0B
- FMBH 847.4M
- IPO Year
- COGT 2018
- FMBH N/A
- Fundamental
- Price
- COGT $6.48
- FMBH $35.02
- Analyst Decision
- COGT Buy
- FMBH Hold
- Analyst Count
- COGT 7
- FMBH 4
- Target Price
- COGT $14.17
- FMBH $45.50
- AVG Volume (30 Days)
- COGT 1.0M
- FMBH 62.7K
- Earning Date
- COGT 05-06-2025
- FMBH 04-23-2025
- Dividend Yield
- COGT N/A
- FMBH 2.74%
- EPS Growth
- COGT N/A
- FMBH 4.76
- EPS
- COGT N/A
- FMBH 3.30
- Revenue
- COGT N/A
- FMBH $319,379,000.00
- Revenue This Year
- COGT N/A
- FMBH N/A
- Revenue Next Year
- COGT N/A
- FMBH $4.53
- P/E Ratio
- COGT N/A
- FMBH $10.63
- Revenue Growth
- COGT N/A
- FMBH 16.50
- 52 Week Low
- COGT $5.88
- FMBH $28.86
- 52 Week High
- COGT $12.61
- FMBH $43.86
- Technical
- Relative Strength Index (RSI)
- COGT 38.02
- FMBH 39.31
- Support Level
- COGT $6.31
- FMBH $35.15
- Resistance Level
- COGT $7.49
- FMBH $36.90
- Average True Range (ATR)
- COGT 0.43
- FMBH 0.98
- MACD
- COGT -0.04
- FMBH 0.07
- Stochastic Oscillator
- COGT 10.90
- FMBH 20.68
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. It also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.